Showing 1,901 - 1,920 results of 2,299 for search 'Patient Number 9', query time: 0.08s Refine Results
  1. 1901
  2. 1902
  3. 1903
  4. 1904
  5. 1905
  6. 1906
  7. 1907

    Evaluation of the quality, reliability, readability of websites on temporomandibular joint pain by Selcen Eser Mısır, Perihan Dalgalı Evli, Kübra Gülnur Topsakal, Merve Aksoy

    Published 2025-01-01
    “…MATERIALS AND METHOD: An internet search was performed on Google Chrome (Google, Mountain View, California, USA) on June 9, 2023, with the keywords “jaw pain” and the links of the first 50 websites were saved. …”
    Get full text
    Article
  8. 1908
  9. 1909

    Estradiol and progesterone levels in early pregnancy after natural, estradiol + progesterone or gonadotrophin stimulated frozen embryo transfer cycle: a randomised controlled trial... by Nina Freiesleben Mørch, Mette Petri Lauritsen, Pernille Fog Svendsen

    Published 2022-07-01
    “…Positive, negative and inconclusive findings will be published in international peer-reviewed journals.Trial registration number NCT04997525, 2020-001218-39.…”
    Get full text
    Article
  10. 1910
  11. 1911
  12. 1912
  13. 1913
  14. 1914
  15. 1915
  16. 1916

    Changes in Uterine Cancer Incidence Rates in Egypt by Saad Alshahrani, Amr S. Soliman, Ahmed Hablas, Mohamed Ramadan, Jane L. Meza, Steven Remmenga, Ibrahim A. Seifeldein, Robert M. Chamberlain

    Published 2018-01-01
    “…The crude rate (CR) was 1.95, 95% CI (1.64–2.25) in 1999–2002; 2.9, 95% CI (2.5–3.2) in 2003–2006; and 3.5, 95% CI (3.1–3.9) in 2007–2010. …”
    Get full text
    Article
  17. 1917
  18. 1918
  19. 1919
  20. 1920

    Prognostic determinants and functional role of PIK3C2G in stage IIb-IIIa lung adenocarcinoma: insights from clinical and molecular analyses by Chao Gao, Jiaqi Zhang, Xin Du, Xuehan Gao, Xiayao Diao, Ke Zhao, Yeye Chen, Shanqing Li

    Published 2025-01-01
    “…Functional experiments in A549 lung adenocarcinoma cells were performed to evaluate the role of the significant genes in tumor progression through cell proliferation, migration, invasion, apoptosis, and cell cycle assays.ResultsThe survival analysis of 877 stage IIb and IIIa lung adenocarcinoma cases revealed significant differences in clinical characteristics and outcomes. Stage IIb patients had a median OS of 58 months compared to 37 months for stage IIIa, with 5-year OS rates of 46.9% and 30.5%, respectively. …”
    Get full text
    Article